In conclusion, the plasma levels of IL-37, as well as TNF-α, IL-6 and IL-17A, were found to be significantly increased in RA patients compared to HCs, and decreased in drug responders following DMARD treatment. Here, IL6 is linked to rheumatoid arthritis.